๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

ChemInform Abstract: Studies on Disease-Modifying Antirheumatic Drugs. Part 3. Bone Resorption Inhibitory Effects of Ethyl 4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-2- (1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) and Related Compounds.

โœ Scribed by Atsuo Baba; Tsuneo Oda; Shigehisa Taketomi; Kohei Notoya; Atsushi Nishimura; Haruhiko Makino; Takashi Sohda


Publisher
John Wiley and Sons
Year
2010
Weight
31 KB
Volume
30
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

โœฆ Synopsis


Studies on Disease-Modifying Antirheumatic Drugs. Part 3. Bone Resorption Inhibitory Effects of Ethyl 4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) and Related Compounds.

-Structure-activity relationships concerning the bone resorption inhibitory effects of compounds (I) are reported. TAK-603 (Id) is effective in preventing bone loss in ovariectomized mice.


๐Ÿ“œ SIMILAR VOLUMES


ChemInform Abstract: Studies on Anti-MRS
ChemInform Abstract: Studies on Pyridone